Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy.

Haematologica · 2025 · PMC12580714 · PMID 40304065

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our analysis, peak lymphocyte count (as a surrogate for CAR-T expansion) was significantly associated with increased risk of tMN, while higher cytokine release syndrome grade showed a trend towards increased risk of tMN.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.